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Resumo 
 
 
A genisteína é um dos fitoestrogénios mais abundantes na soja. Devido à sua 
similaridade química com os estrogénios endógenos, a genisteína pode se 
ligar aos receptores de estrogénio (ERs) presente nas células e desencadear 
uma resposta estrogénica. A sua ação estrogénica pode potencialmente 
interferir com o funcionamento normal de vários sistemas no organismo 
humano, incluindo o sistema reprodutivo que é altamente regulado pelas 
hormonas sexuais. Tem-se verificado um crescente interesse em usar 
genisteína para tratamento e prevenção de doenças como o cancro, 
osteoporose, doenças cardiovasculares, alívio dos sintomas de menopausa, 
entre outros. Há ainda um o aumento do consumo de soja em populações 
ocidentais, como substituto da proteína animal e é usado para produzir 
alimentos para bebés sendo fatores preocupantes porque os efeitos dos 
fitoestrogénios no organismo humano ainda estão sob discussão. Por outro 
lado, estudos animais são contraditórios e estudos humanos são escassos. 
No presente estudo  avaliou-se a ação da genisteína em células de Sertoli 
humanas (hSCs). Essas células são fundamentais para uma espermatogênese 
correta, uma vez que proporcionam suporte físico e nutricional às células 
germinativas. Biópsias de seis pacientes com espermatogênese conservada, 
foram recolhidas numa clínica de tratamento de fertilidade e culturas primárias 
de células de Sertoli humanas foram semeadas e mantidas até atingirem 
confluência. Atingida essa condição, as células foram tratadas com meios 
contendo diferentes concentrações de genisteína, durante 24h. Foram 
realizados  diversos testes de citotoxicidade. Não foram detectadas alterações 
nas hSCs tratadas com genisteína. Conclui-se então que este composto não é 
tóxico para estas células. Posteriormente, efetuou-se a análise de uma das 
vias metabólicas mais relevantes nestas células, a glicólise, que origina 
piruvato que posteriormente  é utilizado para a produção de lactato. Esse 
substrato é uma importante fonte energética para células germinativas. No 
entanto, a absorção e excreção de diferentes metabolitos desta via, além da 
atividade enzimática da lactato desidrogenase, não mostraram variações 
significativas após a exposição das hSCs a genisteína. 
Também se avaliou a influência da genisteína nas taxas de stress oxidativo em 
hSCs, uma vez que a produção de espécies reactivas de oxigénio é comum 
durante o metabolismo celular e, quando não são eficientemente eliminadas, 
podem causar danos irreversíveis em diferentes estruturas celulares podendo 
até levar à morte celular. Os resultados do presente estudo demonstram que a 
genisteína não influenciou as taxas de stress oxidativo. Em suma, conclui-se 
que não foram identificados efeitos nocivos por parte da genisteína sobre os 
parametros analisados nas hSCs. No entanto, isso não significa que a 
genisteína, e outros fitoestrogénios, sejam seguros para o resto do sistema 
reprodutivo. Por esta razão deverão ser efetuados vários estudos no futuro 
para o esclarecimento mais amplo da sua ação.  
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Abstract 
 
Genistein is one of the most abundant phytoestrogens in soybeans. Because of 
its chemical similarity to endogenous estrogens, genistein can bind to estrogen 
receptors (ERs) present in cells and mediate an estrogenic response. Its 
estrogenic action may potentially interfere with normal functioning of various 
systems in the human organism, including the reproductive system which is 
highly regulated by sex hormones. The increasing interest in using genistein for 
treatment and prevention of diseases such as cancer, osteoporosis, 
cardiovascular diseases, relief of menopause symptoms, among others. As 
well as the increasing consumption of soy in Western populations as a 
substitute for animal protein and its use to produce food for infants are 
worrisome factors because the effects of phytoestrogens on the human 
organism are still a matter of intense debate. Animal studies are contradictory 
and human studies are scarce.   
The aim of the present study was to evaluate genistein safety on human Sertoli 
cells (hSCs) in vitro. These cells are pivotal for successful espermatogenesis 
since they provide nutritional and physical support to sperm germ cells. 
Biopsies from six patients, with conserved espermatogenesis, were chosen at 
an infertility clinic and primary cultures of human Sertoli cells were cultured and 
maintained until reaching confluence. Then they were treated with different 
genistein concentrations during 24h. Different citotoxicity test were perfomed. 
No disturbances were found in hSCs treated with genistein. Therefore, we 
conclude that this compound is not cytotoxic to these cells. Subsequently, the 
analysis of one of the most relevant metabolic pathways, glycolysis, in these 
cells was made, which originates pyruvate, that in turn, later, is used for the 
production of lactate. This substrate is an important energy source for germ 
cells. However, the absorption and excretion of different metabolites of this 
pathway, in addition to the enzymatic activity of lactate dehydrogenase, did not 
show significant variations after exposure of hSCs to genistein. Also genistein 
influence on oxidative stress rates in hSCs was evaluated, since reactive 
oxigene species (ROS) production is common during cell metabolism and if not 
eliminated efficiently it can cause irreversible damage on different cell 
structures and may even lead to cell death. The  results of this study 
demonstrate that genistein did not influence oxidative stress rates.  
Alltoghether, we can conclude that no harmfull effects, on the parameters 
analyzed, were caused by genistein on hSCs. Altough it does not mean that 
genistein, and other phytoestrogens, are safe for the remaining of the 
reproductive system more studies regarding this subject are needed for a better 
understanding of their mechanisms of action.   
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I. Introduction 
 
1. Introduction 
  
 In the last decades, there has been an increased interest in 
phytoestrogens, because of growing body of evidence suggesting that these compounds 
can be potentially beneficial to human health and may even prevent or treat diseases 
such as cancer, cardiovascular diseases, osteoporosis, slow down skin aging, boost 
memory and alleviate menopausal symptoms (1-3). However, its similarity to endogenous 
estrogens arises concerns about possible disruptive effects that it can cause, especially in 
the organs and systems regulated by sexual hormones.  
 Genistein (4’,5,7-trihydroxyisoflavone) is a phytoestrogen, a class of 
compounds that include several groups of non-steroidal estrogens easily found in the 
plant kingdom. These compounds, due to their chemical similarity with endogenous 
estrogens, such as 17β-estradiol as shown in Fig.1, can bound to mammalian estrogen 
receptors and trigger an estrogenic response, although a weak one (1, 4, 5).  
 Animal studies have already shown disruptive effects of phytoestrogens on 
fertility. One of the first reported cases (1946) was in sheep, where it was found that 
sheep grazing in fields rich in clover (Trifolium pratense) developed infertility. Apparently, 
clovers are rich in a phytoestrogen subgroup called isoflavones, of which the most 
abundant, in this case, was formononetin. The diet rich on those compounds led to 
dysfunction in the reproductive system of sheep (6). Humans generally do not consume 
clover but consume many products derived from soy, which is also rich in isoflavones, 
particularly daidzein and genistein (7). The increasing use of soy in food industry as an 
alternative source of protein (5), as well as its use as substitute for animal products in the 
diet of many people arises several relevant concerns due to the lack of conclusive 
information on the effects and risks, for the use (or misuse), of phytoestrogens on human 
health.  
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2. Estrogens and Male Reproduction 
 
 For long time estrogens were regarded as female sex hormones. However, 
it was shown that androgens are metabolized to estrogens in both sexes and that the 
latter play an important role by themselves but also as mediators of androgens-associated 
action in many physiological functions. In addition, estrogens are responsible for important 
processes including growth, cardiovascular function, bone mineralization, brain 
masculinization and sexual behavior, by hormone action on different target tissues (8-12). 
In males, most estrogens are produced from androgens in a conversion mediated by 
aromatase, which is mainly present in Leydig cells. However, aromatase activity was also 
detected in germ cells, mature spermatozoa and Sertoli cells in the reproductive tract and  
also in brain, adipose tissue and skin (13, 14). Estrogens circulate in the plasma bound to 
SHBGs and enter in the cells via passive diffusion (15). They act by binding to their 
specific receptors, ER, which exists in two functional isoforms, namely ERα and ERβ, 
localized at cytosolic and nuclear level. When activated, these receptors interact with a 
specific DNA sequence, through DNA binding domain, and activate or repress the 
expression of that gene (16). Both receptors are expressed in male reproductive organs, 
although differently distributed in different cell types. There are differences in the location 
of ERs in the male reproductive tract between different species, even among the nearest 
ones (17-19). However, Sertoli cells and Leydig cells appear to preserve their similarities, 
among species, in the type of ERs they possess. For example, ERα is always present in 
Leydig cells and ERβ in both, plus in spermatozoa ERβ is present too (17-21).  
 In addition to the two classical estrogen receptors, there is yet another 
receptor that can trigger a signal in the presence of estrogens, G-protein-coupled ER1, 
GPER, also known as GPR30, a receptor belonging to a G-protein coupled receptors 
Figure 1 - Chemical structure of 17β-estradiol in relation to isoflavones general chemical structure and to 
genistein. Genistein mainly consists of two aromatic rings linked to a heterocyclic pyrane ring in the center, 
and three hydroxyl groups which are required for binding to the ER. Distance between these groups is similar 
to those of 17β-estradiol. 
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superfamily. Its discovery is quite recent and its functionality is still a matter of debate 
(22). It is known that this receptor is present in different tissues including the male 
reproductive organs. It can be found in Sertoli cells and germ cells and is especially 
overexpressed in seminomas, the most frequent testicular germ cell cancer (23). It has 
been shown that in the presence of estrogen this receptor can trigger estrogenic 
responses in cells that have ERα and ERβ absent (22, 24, 25). Knockout animals for this 
receptor do not exhibit any abnormalities in the reproductive tract and are fertile, however 
some of these animals suffer from impaired production of T cells in the thymus, have 
impaired glucose tolerance, elevated blood pressure and reduced bone growth (26-30). 
 Studies focused on ERα knockout mice showed that absence of this 
receptor leads to infertility and progressive degeneration of testes and efferent ductal 
epithelium. Those mice had normal fetal and afterbirth development until puberty, time 
when was observed an increase in testis volume and weight followed by complete atrophy 
at around 150 days age (15, 31). Another effect caused by the absence of ERα was the 
loss of reabsorption function in epithelial cells of efferent ductules, thus causing an 
accumulation of fluid into the lumen and exerting back pressure into the testis, probably 
the cause for initial testis weight gain. The accumulation of this fluid caused a disruption 
on spermatozoa development and semen concentration, negatively affecting the fertility of 
the mice (32). Spermatozoa with abnormal morphology were also observed in ERα 
knockout mice and these spermatozoa had flagella separated from their heads. With age, 
spermatozoa in these mice progressively decreased in number, motility and fertilizing 
ability, both in vitro and in vivo (15, 31). Sexual behavior was also affected with males 
showing less interest in females. Thus, number and frequency of mounts were 
significantly lower when compared to the wild type mice (31, 33).  
 Interestingly, ERβ knockout mice did not presented significant alterations in 
development, while fertility and mating rates were also maintained normal. Only in aging 
mice was noted hyperplastic prostate and bladder (34). Later, scientists were able to 
create mice lacking both ERs and the characteristics presented were very similar to that of 
ERα knockout mice which highlights again the major relevance of ERα for male fertility 
(35). 
 Other studies were performed in mice lacking aromatase to unravel a 
possible role for this enzyme in male reproduction. Initially those mice had normal fertility, 
sperm parameters and reproductive tract morphology. However, throughout lifetime, 
occurred a decrease in spermatozoa count and sperm motility and loss of sperm fertilizing 
potential. Spermatozoa count decrease was mainly due to low survival rates of round 
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spermatids, which leads to a progressive impairment of spermatogenesis. Number of 
mounts was also decreased contributing to the lower fertility rates observed in these mice 
(36-38).  
 In human patients, congenital estrogen deficiency and estrogen resistance 
is suggested to be not so detrimental to reproductive function as in mice. However, these 
individuals share a common trait with estrogen resistant mice, impaired sperm motility, 
and both aromatase-deficient mice and men have premature germ cells arrest, which is 
responsible for reduced sperm count (39). These individuals undergo normal puberty, 
have normal external genitalia and prostate and no gender-identity disorders. However, 
they exhibited impaired bone mineralization leading to osteoporosis/osteopenia and 
abnormal epiphyseal maturation associated with continuing linear growth and bone pain, 
eunuchoid body proportions, insulin resistance and impaired lipid and glucose 
metabolism. Gonadotropins and testosterone levels range from normal to elevated, while 
estrogen is below the range of detection (9, 40-46). It is important to note that phenotypes 
displayed on knockout mice and in human patients, sharing the same deficiencies either 
in ERα or aromatase, were not exactly the same, especially in behavioral aspects (39). 
These results show that data obtained with animal studies cannot be always directly 
extrapolated to humans, particularly concerning hormonal response and signaling. 
Nevertheless, all studies clearly support that estrogens are key players for male 
reproduction. 
 
 
3. Phytoestrogens Source  
 
 In nature, phytoestrogens occur in different vegetables, fruits and whole grains 
commonly consumed by humans. Isoflavones are mostly abundant in Fabaceae family, 
mainly soybeans (Glycine max), they can also be found in other legumes such as the 
common bean (Phaseolus vulgaris). Other plants rich in isoflavones are red clover 
(Trifolium pratense), chickpeas (Cicer arietinum), alfalfa (Medicago sativa), kudzu 
(Pueraria lobata), licorice (Glycyrrhiza glabra) and some Chinese medicinal herbs, such 
as Genista tinctoria and Sophora subprostrala (1, 47-52). 
 Soy was not originally cultivated for human consumption, but for its 
nitrogen fixing abilities because rice, which is the base of Asian diet, is nitrogen-depleting 
to soil. Also, soy is difficult to digest, and it was incorporated into the Asian diet mostly in 
fermented forms, such as soy sauce, miso, tempeh and natto. Tofu is also highly 
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consumed in the East but in contrast to the other soy products it has more phytoestrogens 
since it does not undergo fermentation, because fermentation is a process which makes 
soy products to lose some of their phytoestrogens. However, soy products highly 
consumed in the West, like soy milk, soy yogurts, soy-based protein powders, beverages, 
baked goods, tofu, and others do not undergo fermentation and thus, they retain most of 
their phytoestrogens (5, 53).   
 Soy infant formula (SIF) is another soy based product that raises concerns. 
SIF is an infant food made using, among different components, soy protein and it has 
become quite popular as a replacement for human milk or cow milk formula, especially for 
lactose-intolerant babies or in vegan families. Based on 2009 market data, sales of soy 
formula range from 2-7% of total infant formula sales in Europe and about 12% in the 
United States (National Institute of Environmental Health Sciences – U.S.).  Although 
there have been no specific health problems documented in human infants receiving soy 
formula, its safety has been questioned duet to its high isoflavone content (54). It was 
shown that infants fed on SIF have phytoestrogen intake 6-11 fold higher per kg of body 
weight than that seen in adults consuming a diet rich in phytoestrogen (55). Such high 
levels of phytoestrogens are expectable because SIF represents 100% of an infant diet 
while adults consume a variety of different products, so even if a diet in adults is high in 
soy, its total percentage on diet will not be as high as on infant fed on SIF. Plasma levels 
of isoflavones on SIF fed infants were 13 000-22 000 times higher than those of 
endogenous estradiol, which is worrisome because prolonged neonatal exposure to such 
high levels of phytoestrogens may potentially disrupt normal development and the function 
of reproductive organs, since it is in this age that testes are structurally organized and 
Sertoli cell and spermatogonia numbers are established, which will ensure normal 
spermatogenesis initiated at puberty (55, 56).  
 Thus, The National Toxicology Program (NTP) Center for Evaluation of 
Risks to Human Reproduction, convened an expert panel on 2009 to evaluate the safety 
of SIF, based on opinion of experts and a discussion on the scientific publications 
available at the moment of the meeting. The NTP used a five-level scale in its conclusions 
to characterize the likelihood of an adverse human health effect resulting from exposure to 
a substance or chemical, in this case soy infant formula. The levels were divided in 
concern: serious, regular, some, minimal or negligible. Under this evaluation, the NTP 
expressed minimal concern for soy infant formula consumption (National Institute of 
Environmental Health Sciences – U.S.).  Nevertheless, this is still a matter of debate and 
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phytoestrogens sources and mechanisms of action are on spotlight and remain a focus of 
research.  
 
4. Phytoestrogens Metabolism  
 
 Phytoestrogens are known to be metabolized by intestinal bacteria and 
then absorbed. They are also conjugated in the liver, circulate in plasma and excreted in 
the urine (3). Thus, the overall effects of phytoestrogens can be influenced by any of 
these metabolic pathways.   
 Isoflavones mainly exist in soy foods as glycoside conjugates, genistin for 
genistein and daidzin for daidzein (57-59). They are highly polar and water-soluble which 
difficult their absorption by intestinal epithelium. However, in the intestine by action of both 
intestinal mucosal and bacterial β-glucosidases and lactase-phlorizin hydrolase, 
isoflavone glycosides are hydrolyzed to respective aglycones, that are directly absorbed 
and undergo hepatic metabolism, or further metabolized by intestinal microflora into other 
metabolites (2, 59). In the colon, daidzein can be further metabolized to equol (about 
70%) or O-desmethylangolensin (5-20%), and genistein can be metabolized to p-
ethylphenol which does not exert estrogenic activity. About 40.1-58.3% of total genistein 
and genistein administrated are not absorbed and eliminated in the feces. A general 
metabolic scheme of gut microflora transformation of these compounds is presented in 
Fig.2 (60-64). When absorbed, isoflavones bind to SHBG and circulate in the organism or 
undergo enterohepatic circulation. When in liver, they can be conjugated with glucuronide 
and/or sulfate groups at the 4’- and 7-hydroxyl groups and return to circulation or be 
excreted in the urine and bile  (47, 60, 65-67).  Isoflavones in their glycoside form have 
weaker biological activity than the corresponding aglycones and the capacity of producing 
these metabolites differs among individuals, mainly due to differences in gut 
microorganisms (2, 59, 68). 
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According to recent data, western populations tend to consume more unfermented soy 
products which in turn are richer in phytoestrogens, but switching to fermented soy 
products would not be the solution to decrease phytoestrogens intake. Studies have 
demonstrated that during the consumption of fermented and unfermented soy products, 
the urinary excretion of isoflavones was approximately the same, suggesting that 
fermentation increases the availability of isoflavones in soy products (60, 69). However, it 
is known that diet can also influence phytoestrogen digestion. Diets low in fat and rich in 
fiber, typical of Eastern populations, are associated with lower estrogen absorption levels 
in the intestine. This decrease may result due to lower β-glucuronidase activity of 
intestinal bacteria, observed in individuals consuming this type of diet or due to an 
increase in SHBG values, trait commonly seen in vegetarian individuals, which probably is 
caused by the entry of phytoestrogens into the portal circulation in very high amounts and 
consequent stimulation of this globulin production in the liver, thus clearance rates of 
estrogens are greater on these individuals (63, 70). On the other hand, Western 
populations diet is richer in fat and lower in fiber, which makes estrogen absorption easier 
and even if their daily soy consumption is lower, plasma levels of estrogen/phytoestrogen 
Figure 2 - General chemical transformation of genistein (1,2,3) and daidzein (1’,2’,3’) by the gut 
microflora. Glycosides are hydrolyzed to the respective aglycones, genistin is converted to genistein 
and further to 3 p-ethylphenol which does not exert estrogenic activity at this stage. Daidzin is 
metabolized to daidzein and then to equol which, in contrast to the genistein metabolite exerts 
estrogenic activity, better than the daidzein itself. 
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absorbed may reach the amount observed in Eastern populations, or even higher. What is 
worrisome is that soy usage in Western diet is rising significantly, since it is often used as 
animal protein substitute in ready meals available on supermarkets, either as meat 
substitute or as bulking agent, also as a promotion of a healthy life style and 
vegetarianism. This incorporation of soy products in Western diet style, rich in fat and low 
in fiber, can make these populations be exposed to high levels of phytoestrogens (56, 70).  
It should also be noted that Eastern population consume high quantity of soy products 
during centuries and thus, they may have evolved to become more genetically resilient to 
estrogenic insults whereas Western populations started do consume soy not that long 
ago, making them more susceptible to possible endocrine disruption effects (56). 
 
 
5. Chemistry and Action of Phytoestrogens  
 
 Main classes of phytoestrogens are flavonoids (flavones, flavonols, flavanones, 
isoflavonoids), lignans, stilbenoids, chalcones as well as miscellaneous chemicals. 
However, the greatest estrogenic activity is exerted by isoflavones, flavones, flavonols, 
flavanones, lignans and chalcones, of which most common are isoflavones and lignans.  
Special attention is given to isoflavones, where genistein belongs, since they are higly 
consumed by humans and they include subgroups as isoflavones, isoflavanones, 
pterocarpanes, coumestans, and others (4, 47, 71, 72). 
Chemically, isoflavones are characterized by a 15-carbon (C6-C3-C6) skeleton 
and have the B-ring linked to the C-3 of the central heterocyclic pyrane ring (C), rather to 
the C-2 which happens in flavones. Genistein mainly consists of a heterocyclic pyrane ring 
(C) in the center, which links two aromatic rings (A and B), also has three hydroxyl groups 
(Fig.3). Hydroxyl groups are pivotal for estrogenicity of a molecule since they form 
hydrogen bonds with key functional amino acids of the binding part of the receptor. The 
other requirement to bind ER is the distance between O-O of hydroxyl groups that should 
be between 10.9Å and 12.5Å, simulating the 3-OH and 17β-OH hydroxyl groups of 17β-
estradiol. It is thought that hydroxyl group at C-5 of genistein is responsible for its affinity 
to ERs, because daidzein, which is identical to genistein only lacks this hydroxyl group, as 
seen in Fig.3, and essentially has no binding activity to either of ERα or ERβ (4, 47, 73-
75).  
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Figure 3 – Isoflavone and daidzein chemical structure in relation to genistein. Both 
genistein and daidzein belong to the isoflavone subgroup and that is why their chemical 
structure is the same with only one difference, the hydroxyl group at C-5 which grants 
genistein its ability to bind to ERs. 
 
 
As for genistein, it binds to both ER isoforms with moderate affinity but 
demonstrates a preference for ERβ, with a 30-fold higher affinity (3, 75, 76). Also, 
genistein is known to exert mixed (agonist/antagonist) properties on both receptors in an 
organ-dependent manner, depending on the receptor content of specific tissue (ERα and 
ERβ amount). Antagonist response usually is a result of competition between 
phytoestrogens and estrogens for ERs (4, 74, 77, 78).  
 Phytoestrogens not only interact with ERs but can also exert indirect 
estrogenic response by alternative mechanisms. Phytoestrogens interfere with the 
synthesis of steroid hormones by inhibiting specific enzymes, such as aromatase, which is 
responsible for the conversion of androgens to estrogens. Phytoestrogens may also affect 
the clearance rates of androgens and estrogens by displacing them from SHBG. 
Apparently, production of these globulins in the liver is stimulated by phytoestrogens and 
thus, this will affect the total amount of free estrogens in blood circulation and thereby 
cause an indirect estrogenic effect (4, 70, 71, 79, 80). 
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6. Phytoestrogens also mediate non-estrogenic effects  
 
 Besides their estrogenic activity, phytoestrogens, can also exert non-
genomic actions such as tyrosine kinase inhibition (81, 82) which in turn affects cell 
signaling. Also, genistein was reported to inhibit topoisomerase II activity (83-85) and 
increase the activity of some antioxidant enzymes, including catalases, superoxide 
dismutases, glutathione peroxidase and glutathione reductase (86-88). Tyrosine kinase 
and DNA topoisomerase II inhibition together with antioxidant enzyme stimulation are 
undoubtedly important factors responsible for phytoestrogen anticarcinogenic activity.  
 Another phytoestrogen target of these compounds are steroidogenic 
enzymes. Genistein directly inhibits 3 and 17β-hydroxysteroid (17β-HSD) dehydrogenase 
activity, thereby disrupting the conversion of androstenedione to testosterone and 
androstenediol to androsterone (89). Although genistein action on its own on aromatase 
enzyme is weak (90), its effect on reduction of androgens production by inhibiting 3 and 
17β-HSD will indirectly affect estrogen synthesis. Coumestrol and genistein were also 
shown to reduce 17β-hydroxysteroid oxidoreductase activity which is responsible for 
conversion of estrone to the more potent 17β-estradiol, thus decreasing the availability of 
the highly active endogenous estrogens (91).  
 
 
7. Genistein effect on male fertility: research results in last years from 
benefits to subfertility or infertility  
 
 From the foregoing, we can conclude that estrogens are extremely 
important for the proper functioning of the reproductive system, not only in female but also 
in male, and that phytoestrogens can potentially disrupt its normal functioning. 
 Great interest in phytoestrogens, genistein and daidzein in particular, due 
to their increasing consumption in Western populations and their potential therapeutic 
effects made them the focus of many studies in the last decades. Another reason for the 
increasing study of phytoestrogens is due to their chemical similarity with endogenous 
estrogens and the controversies that this generated about its safety. There is a need to 
determine if their estrogenic effects can have disruptive effects on the functioning of our 
organism or not, and verify if fertility is somehow affected. 
 Most of studies are performed on rat/mice and only few studies are 
available about the effects of genistein, and phytoestrogens in general, on human fertility. 
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7. 1 Rat/mice studies 
 
 Rodent studies conditions are very varied, regarding the time of exposure 
and genistein dose used, as well as the age at the time of administration. Also, results are 
quite contradictory, even among studies with similar conditions. It should be noted that 
there are few studies that report beneficial effects of genistein on the reproductive system, 
most do not find alterations and others affirm that there is a high degree of disturbance in 
some of the studied parameters. For example, the period of life when animals where 
submitted to phytoestrogens, genistein inclusively, is crucial and the results attained are 
different accordingly with the period studied. Prenatal exposure has been shown to 
negatively affect the fertility of the animal when it reaches adulthood, exposure of adults 
has also resulted in temporary disturbance of the fertility, however, postnatal exposure, 
pre-pubertal, during puberty and chronic exposures (over the lifetime of the animal) had 
both, neutral results (no effects observed) and cases in which some fertility interference 
occurred, as summarized in Table 1. It is quite interesting that in two multigenerational 
studies, where several generations of animals were continuously exposed to 
phytoestrogens (including genistein), their fertility, in general, was unaffected, it was only 
noted a slight decrease in the number of pups per litter in the second generation, but this 
effect has been attenuated in subsequent generations (92, 93), thus indicating that 
probably, continued exposure to phytoestrogens results in some kind of resistance to 
them.  
 Weight of the reproductive organs in most cases was unaffected, which seems to 
ensure the safety of genistein and phytoestrogens in general, however sperm evaluation 
parameters show some disturbances, as summarized in Table 1. Of the various studies 
known in the literature, most report a reduced sperm count and motility, and even 
morphological anomalies were found, this may explain the decrease in offspring. Serum 
levels of testosterone also appear to be slightly decreased in many cases, on the other 
hand, FSH and LH do not appear to deviate much from normal levels, cases of slight 
decrease have been reported as well as cases in which there was no variation (Table 1). 
Anyway, this did not affect the sexual  behavior of these animals, although in one case a 
decreased interest of males by females was reported, yet this did not affect drastically the 
fertility in general (94, 95). 
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  Antioxidant power of genistein, and the beneficial effects of this action to 
the reproductive system has been the only parameter consistently evaluated as positive in 
most studies (73, 74, 102, 103). Lack of concordant results on the effects of genistein on 
reproductive system does not support its safety- Jorge M. Naciff et all., 2005, carried out a 
study in which genistein, among other phytoestrogens, was able to alter the expression of 
several genes in reproductive organs in a dose dependent manner. About 46 genes were 
up- or down-regulated by genistein (96), although it is not yet known whether all these 
modifications have positive or negative effects, is nonetheless a worrying fact that must be 
taken into account and carefully discussed. Other studies observed a decrease in the 
production of certain mRNAs in male reproductive organs, such as ERα mRNA in the 
testes and epididymis (97), although these mice did not have alterations in testis weight, 
sperm count and sperm motility in adulthood. Decreased levels of mRNA involved in 
ribosome function in testis, transcripts coding for androgen-response genes in Sertoli cells 
and Gapd-s (involved in sperm glycolysis and mobility) were significantly reduced, 
although without significant effects on fertility (95). 
 Another study in rats reported that genistein aglycones, its most active 
form, are able to get out of the maternal circulation, pass through placenta and enter fetus 
blood circulation, and that the difference in concentration of aglycones in fetal serum was 
only 5-fold lower than maternal. In addition, brain levels of fetal aglycones were very 
similar to maternal (98), and although studies done with pre-natal and multigenerational 
genistein exposure did not reveal significant implications for mice fertility, Table 1, the 
possibility of exposure to phytoestrogens during development still remains a matter of 
concern and debate. 
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ABLE 1 
Effects of genistein/soy phytoestrogens exposure on rat/mice Positive effects Negative effects No change 
Age and time of exposure 
Prenatal  -(96, 99, 100)  
Postnatal  -(101) (102) 
Pre and postnatal  -(95, 103) (104, 105) 
Prepubertal   (106) 
Pubertal  -(107) (108) 
Adult +(109) -(110-113)  
Chronic  -(114) (115) 
Multigenerational   (92, 93) 
Serum hormone levels 
Testosterone ↑*(87) ↑(109) 
↓(99, 100, 103, 107, 112, 
114) 
(95, 102, 116) 
FSH ↑*(87) ↓(103, 112) (104, 113) 
LH ↑*(87) ↓(103, 104, 112) (95, 113) 
Estradiol  ↓(92)  
Weight 
Testis  ↓(94, 99, 111) (97, 104, 105, 108, 115) 
Epididymis  ↓(104, 111) (108, 115) 
Prostate ↑(92) ↓(94, 111)  
Seminal vesicles ↑(92) ↓(101, 111) (105) 
Sperm parameters 
Count ↑(109) 
↓(94, 95, 100, 107, 108, 
111, 113) 
(97, 102, 104, 105, 115) 
Motility ↑(108, 109) ↓(94, 107, 111, 114) (97, 105) 
Morphology ●(87) ○(111, 112) (115) 
Viability ↑*(87) ↓(94)  
Other parameters 
Antioxidant capacity ◊(87, 88, 117, 118)   
Gene/mRNA expression 
alteration 
↑”(96) ↓”(95-97, 114) (105) 
Offspring  ↓(95, 100, 114) (106) 
Sexual behavior  ↓¹(94) (95) 
Anogenital distance  ↓(99) (105, 106) 
+ Ameliorating effects on fertility after genistein exposure at different age/developmental stage;  -  Detrimental effects on fertility after genistein exposure 
at different age/developmental stage ↑ Increase;  ↓ Decrease;  ↑* Increase from abnormally low levels to normal levels;  ● Increase of the number of 
morphologically normal spermatozoa;  ○ Decrease of the number of morphologically normal spermatozoa;  ◊ Reduction of oxidative stress;  ↓¹ Reduced 
interest in mating;  ↑” Gene up-regulation;  ↓” Gene down-regulation. 
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7. 2 Human studies 
 
 Studies with humans are scarce, which is understandable due to the 
difficulty of recruiting volunteers and the ethical factors involved. Most of these studies are 
based on the analysis and comparison of data on the consumption of phytoestrogens and 
their possible relation with changes in the semen parameters.  
 A study based on data from an infertility clinic has associated  consumption 
of soy products to a lower sperm count (119). That study is in line with another report 
conducted in China in which about 1000 men were recruited. That group consisted of men 
with idiopathic infertility and healthy ones, and high levels of daidzein, genistein and 
secoisolariciresinol were associated with lower sperm count and motility (120). A meta-
analysis conducted by David Lim and Ian C. Shaw (121), on the consumption of 
phytoestrogens and sperm concentration in the USA and China, also reached a slight 
association between phytoestrogen consumption and lower sperm count but this 
association was considered insignificant. It is also not certain whether phytoestrogens 
may be the cause of this decrease, since there are many other environmental factors that 
may be involved. Also, administration of 40 mg of isoflavones per day to healthy men for 2 
months did not induce any changes in semen parameters, in serum hormone levels or in 
testis size (122). A study conducted with couples desiring pregnancy, showed that higher 
levels of genistein and daidzein were associated with increased abnormalities in semen 
morphology although this did not influence the fertility of the couples (123). Another study 
with couples from an infertility clinic that were undergoing fertility treatment in which the 
male partner of the couple was, or not, a consumer of soy products, were evaluated for 
the success of in vitro fertilization, embryo quality, implantation and live at birth, and no 
relation was found between these parameters and soy consumption (124). Measurement 
of hormone levels such as testosterone and LH in men who consumed soy or isoflavones 
whether in the diet or as supplements, also did not found significant variations (78, 125).  
 It appears that phytoestrogen consumption is associated with a lower 
sperm count but its association with infertility is difficult to establish, yet there is a case 
study reporting that phytoestrogens helped to treat infertility, temporarily, in a man with 
severe oligospermia caused by partial sperm maturation arrest at a spermatidic stage. 
This man had altered sperm count, motility and morphology and was given 80mg/day of 
phytoestrogens for 6 months, at 3 months semen parameters significantly improved and 
resulted in pregnancy, at the end of 6 months semen parameters improved even more. 
After a period of 6 months wash-out sperm parameters returned to baseline values (126). 
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 In sum, experimental animal models differ from human studies. In humans, 
the consumption of genistein is not associated with alterations in the male reproductive 
organs. However, it is verified a trend to a lower sperm count, also a small variation in the 
hormonal levels and the morphology of the spermatozoa were found, yet, no influence on 
the fertility of the analyzed individuals. In turn, results of the studies in rats/mice are quite 
diverse and contradictory, many of the parameters analyzed in the experiments, in half of 
the cases, present changes and in the other half do not present any alterations. One of 
the factors in common with human studies is the decrease in sperm count and while in 
humans there was no influence of the phytoestrogen consumption on fertility, in animals a 
reduction, on similar studies, was noted. In animals, was also found that the consumption 
of phytoestrogens can alter the expression levels of several genes in the testis and it can 
result in up- or in down-regulation depending of the treatment. Another important 
characteristic found in the reproductive organs of the studied animals was the antioxidant 
power that phytoestrogens exert, which is indeed a beneficial factor for cellular function.  
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II. Aims of Project 
 
Since genistein is highly present in human nutrition due to increasing soy 
consumption and its estrogenic activity is undeniable and safety yet to be proven, we aim 
to establish a link between genistein exposure and its influence on male reproductive 
potential. For that we evaluated human Sertoli cell metabolic profile, since these cells are 
pivotal for spermatogenesis by providing physical and nutritional support for germ cells. 
Part of the metabolic study was characterized by the lactate production pathway, its major 
components and the study of the lactate dehydrogenase. This pathway was chosen 
because lactate is used as main energy source in germ cells. 
However, firstly we evaluated the cytotoxicity of genistein in these cells by 
exposing these cells to different concentrations. The oxidative stress rates in human 
Sertoli cells exposed to genistein were also evaluated. Overall, we proposed to study the 
metabolic and oxidative profiles of human Sertoli cells exposed to genistein in order to 
determine if this phytoestrogen can alter the nutritional support of spermatogenesis, which 
would have a crucial effect for sperm production. 
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III. Methods 
 
1. Chemicals 
 
Genistein (G6649-00025MG): Sigma-Aldrich (St. Louis, MO, USA); Dulbecco’s 
Modified Eagle Medium (DMEM), Ham’s F-12 (F12) and Fetal Bovine Serum (FBS): 
Biochrom (Leonorenstr, Berlin, Germany); Insulin-Transferrin-Sodium (ITS): #41400-045 
Gibco (Grand Island, NY, USA); JC-1 Molecular Probes: Eugene (OR, USA); LDH 
Enzymatic Assay Kit and M-PER Mammalian Protein Extraction Reagent: Thermo 
Scientific (Waltham, MA, USA); Thiazoyl Blue Tetrazolium Bromide (MTT): AMRESCO 
(OH, USA) were purchased. All other chemicals/reagents were obtained from Sigma-
Aldrich (St. Louis, MO, USA), unless specifically stated. 
 
2. Testicular tissue selection and ethical issues 
 
Sertoli cells required for the work were isolated from human testicular biopsies. 
Testicular biopsies were obtained from patients seeking for fertility treatment in the Center 
for Reproductive Genetics Prof. Alberto Barros (Porto, Portugal), after informed written 
consent. Biopsies from patients who had preserved spermatogenesis and were seeking 
for treatment due to anejaculation (neurologic, psychological or vascular), vas deferens 
damage or vasectomy were used. 
 
3. Primary culture of human Sertoli cells  
 
Studies were done in accordance with the Helsinki Declaration. The study of 
patients and biopsies was done according to Guidelines of Local, National and European 
Ethical Committees in the Center for Reproductive Genetics Prof. Alberto Barros (Porto, 
Portugal). Human SCs where isolated form cells left in tissue culture plates after patient’s 
treatment by a method previously described by (127). Cells were transferred to culture 
flasks (Sarstedt, Nümbrecht, Germany) where they grew till reaching confluence. hSCs 
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culture medium consisted of a mixture of DMEM with Ham F-12 (1:1), suplemented with 
HEPES, sodium bicarbonate, D-Glucose, 50µg/ml of gentamicin, 50U/mL penicillin, 
50mg/mL streptomycin sulphate, 0.5mg/mL fungizone and 10% of inactivated FBS. 
Medium was changed once in 4 days and cells were kept in an incubator which had the 
following conditions: 5% CO2, 95% O2 at 33-34°C. 
 
4. Preparation of medium containing genistein (treatment medium) 
 
The initial stock of genistein was made with the dissolution of pure genistein in 
DMSO, organic solvent, to a final concentration of 185 mM. Subsequent dilutions were 
made from this stock so as to obtain treatment media at a concentration of 10 µM, 1 µM, 
0.1 µM, 0.01 µM and 0 µM, the latter did not take genistein but rather the vehicle (i.e. 
DMSO), as all media were adjusted to have 0.005% of the vehicle (10 μM). The treatment 
medium consisted of ITS, genistein and 0.005% DMSO. ITS medium is equal to the hSCs 
culture medium but instead of having FBS it is supplemented with ITS. The concentrations 
of genistein chosen were based on the literature in which the amount of circulating 
genistein, in the plasma, was evaluated in different populations with different consumption 
habits of products containing the same (128). The concentration of 0.01 μM corresponds 
to a value normally observed in European populations, thus populations that do not 
commonly consume soy products (129). On the other hand, the concentration 1 μM is 
observed in Asian populations (130, 131) that usually consume large quantities of soy 
products, and the concentration of 0.1 μM was chosen as intermediate concentration The 
concentration of 10 μM is a supraphysiological dose and 0 μM is an absolute control, cells 
completely devoid from genistein influence (132). 
 
5. Experimental groups 
 
For this work biopsies of 6 different people that had conserved spermatogenesis 
as mentioned above were chosen, when cells of each biopsy in the culture flask reached 
confluence they were divided by culture plaques. After cultured, the cells were maintained 
until reaching a confluence of 90-95%, when this condition was reached the culture 
medium was replaced by treatment medium. After medium replacement, cells were placed 
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in the same incubator where they were before, for 24 hours. At the end of that time cells 
and medium were collected for further analysis. Cell viability and counting was performed 
with 0.4% trypan blue stain (Sigma-Aldrich, USA) in a LUNA™ Automated Cell Counter 
(Logos Biosystems, South Korea). The resulting pellets were stored at -80°C. 
 
6. Cell lysis and protein extraction 
 
Cells were lysed using the M-PER solution supplemented with inhibitor cocktail 
and sodium ortho-vanadate. From the lysate protein quantification was performed using 
the Pierce™ Microplate BCA Protein Assay Kit – Reducing Agent Compatible (Thermo 
Scientific, Waltham, MA, USA), which already included standard solutions and the blank. 
The reading was made at 570nm on Multiskan™ FC Microplate Photometer (Thermo 
Scientific, Waltham, MA, USA). The amount of protein in the samples was calculated 
based on the standards, according to the manufacturer’s instruction. 
 
7. Lactate dehydrogenase (LDH) enzymatic assay 
 
LDH activity was determined using LDH Enzymatic Assay Kit (Thermo Scientific, 
Waltham, MA) following the manufacturer's instructions. LDH activity was measured in 
both extracellular (medium at the end of 24 hours of treatment) and intracellular medium. 
Levels of LDH activity were measured spectrophotometrically; reading was done at 
490nm and at 630 using an Multiskan™ FC Microplate Photometer (Thermo Scientific, 
Waltham, MA, USA). LDH activity was calculated as units per milligram of protein using 
the molar extraction factor (ε) and in the end presented as fold variation to control. 
 
8. Cells metabolic activity assay 
 
Metabolic activity of the cells was assessed using tetrazolium dye MTT assay. 
Living cells are able to reduce tetrazolium dye to its insoluble form formazan, which has a 
purple color. Briefly, cells were seeded into 96-well culture plate, the same number of cells 
per well approximately, and maintained until reaching a confluence of 90-95%. Cells were 
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then treated for 24h with media containing genistein, after that this medium was removed, 
and cells were washed with PBS. 250μL of ITS medium was added to each well plus 25µL 
of MTT solution (5mg/mL) and left to incubate in an incubator (37ºC) during 2-4h, until the 
formation of crystals. The liquid was discarded and 250μl of DMSO was placed to dissolve 
the formazan crystals and left to agitate for 15 minutes in the dark. 100μL of each well 
was transferred to a 96-well plate and absorbance was read at 570nm and 655nm in the 
iMark™ Microplate Absorbance Reader (Bio-Rad, California, USA). 
 
9. Sulforhodamine B (SRB) assay 
 
To evaluate the influence of genistein on the proliferation of hSCs, SRB assay was 
performed based on (133). Briefly, cells were cultured in a 96-well culture plate, each well 
with the same number of cells approximately. When cells reached a confluence of 60-
70%, they were treated with treatment medium for 24h. At the end of that time cells were 
fixed with a mixture of 1% acetic acid and 99% methanol, overnight at -20ºC. The next 
day cells were stained with 0.05% (w/v) SRB dissolved in acetic acid 1% for 1h, the 
unbound SRB was washed out with acetic acid 1% while the bound SRB was extracted 
with 10Nm Tris base (pH 10) in a shaker for 10 minutes. A blank was made with only Tris 
base (pH 10) and absorbance was read at 492nm. To obtain a dose-response, control 
was taken as 100% and the other groups were evaluated relative to the control. 
 
10. Mitochondrial membrane potential 
 
The membrane potential of the mitochondria in hSCs was measured using the JC-
1 fluorescent probe, using a slightly modified method as described in (134). The 
accumulation of JC-1 within the mitochondria depends on the membrane potential of the 
same, therefore if mitochondria are functional their membrane potential is high and JC-1 
aggregates are formed inside of them. On the other hand, when mitochondria are 
dysfunctional their membrane potential is low and JC-1 is present mainly in the form of 
monomers. The ratio between the monomers and the aggregates allows to verify if the 
mitochondria are functional or not. The greater the ratio between the two, the greater is 
the depolarization of the mitochondria. hSCs were cultured in a 96-well culture plate with 
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approximately the same number of cells per well. When cells reached a confluence of 
about 60-70% they were exposed to treatment medium for 24h, when time was over this 
medium was taken out and was put 100μl/well of JC-1 staining solution (1μg/mL) 
dissolved in DMEM:F12 medium (1:1, pH 7.4) containing 1% FBS, during 15 minutes at 
37ºC. At the end of that time cells were washed with PBS and given 100μl/well of 
DMEM:F12 medium (1:1, pH 7.4) supplemented with 1% FBS, the fluorescence intensity 
was measured immediately at 37°C using Cytation™ 3 Cell Imaging Multi-Mode Reader 
(BioTek, Winooski, USA). The JC-1 monomers are detected at 485/535nm 
(excitation/emission), while the aggregates at 550/590nm (excitation/emission). 
 
11. Nuclear magnetic resonance (¹H-NMR) spectroscopy and spectral 
analysis 
 
The spectrum of the extracellular medium was obtained using a Varian 600-MHz 
spectrometer equipped with a 3-mm indirect detection probe with z-gradient (Varian 
Instruments, Palo Alto, CA, USA) and quantified according to what is described in (135). 
Sodium fumarate (final concentration of 1 mM) was used as an internal reference (6.50 
ppm) for quantification of the following metabolites present in the extracellular medium of 
cells under study (multiplet, ppm): lactate (doublet, 1.33), alanine (doublet, 1.45), α-
glucose (doublet, 5.22), pyruvate (singlet, 2.35), glutamine (triplet, 3.77), acetate (singlet, 
1.90). The relative ¹H-NMR resonance areas and the concentration of the metabolites 
present in the medium were calculated as described in (135). 
 
12. Western Blotting 
 
Total proteins from hSCs were isolated with the help of M-PER, and quantified as 
described above. The resulting protein was mixed with sample buffer (60mM Tris.HCl, pH 
6.8; 10% glycerol; 2% SDS; 5% β-mercaptoethanol and 0.01% bromophenol blue (1%)) at 
a ratio of 1:5, the remaining volume was filled with PBS 1x concentrated to give a final 
volume of 35μL for each sample. Protein preparations were denatured at 55°C for 10 
minutes. Proteins were fractionated in 12.5% polyacrylamide gel for 90 minutes. At the 
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end of the electrophoresis proteins were transferred to the previously activated 
polyvinylidene difluoride membrane which was then blocked for 90 minutes at room 
temperature in a 5% nonfat milk solution. Afterwards, the membrane was incubated 
overnight at 4°C with rabbit anti-LDH (1:10 000, Abcam). Also, the membrane was 
incubated with mouse anti-β-actin (1:5000, Thermo Scientific) as protein loading control. 
After overnight incubation the membrane was incubated with secondary antibody, mouse 
anti-rabbit IgG-HRP (1:5000, Santa Cruz Biotechnology) or goat anti-mouse IgG-HRP 
(1:5000, Santa Cruz Biotechnology) in case of β-actin. The membrane was read in 
ChemiDoc™ XRS+ System (Bio-Rad Hemel Hempstead, UK) previously reacted with 
WesternBright ECL HRP substrate solution (Advansta, California, USA). The density of 
the bands was measured with the help of Image Lab 5.2 program (Bio-Rad, UK) using the 
tool that exists in the program for this purpose. Density of the bands obtained was divided 
by the density of the bands of the corresponding β-actin and expressed as fold variation to 
control (136).  
 
13. Evaluation of carbonyl groups, lipid peroxidation and nitration 
 
Protein carbonylation, lipid peroxidation and nitration are often used as biomarkers 
for oxidative stress and they can be evaluated by measuring their resulting products such 
as 2,4-dinitrophenyl (DNP), 4-hydroxynonenal (4-HNE) and nitro-tyrosine, respectively. Its 
content in hSCs, after exposure to genistein, was measured by using slot-blot technique 
with the Hybri-slot manifold system (Biometra, Göttingen, Germany). The resulting PVDF 
membranes were incubated with the respective antibodies. For the measurement of the 
carbonyl groups, protein samples were derivate with 2,4-dinitrophenylhydrazine (DNPH) 
to obtain DNP, according to the method previously described (137). As for lipid 
peroxidation and nitration analysis, samples were diluted in PBS to obtain a concentration 
of 12µg/µl. Samples were blotted in the slot-blot and the resulting membranes were 
incubated overnight at 4°C with respective antibodies, rabbit anti-DNP (1:5000, D9656, 
Sigma-Aldrich, St. Louis, MO, USA), goat anti-4-HNE (1:5000, AB5605, Merck Millipore, 
Temecula, USA) and rabbit anti-nitro-tyrosine (1:5000, 9691, Cell Signaling Technology 
Leiden, Netherlands). Primary antibodies where marked with secondary antibodies anti-
goat: rabbit anti-goat IgG-AP (1:5000, A4187, Sigma-Aldrich, USA) and anti-rabbit: goat 
anti-rabbit IgG-AP (1:5000, sc-2007, Santa Cruz Biotechnology, Heidelberg, Germany), 
respectively. The reading was done with the help of ECF™ substrate (GE Healthcare, 
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Buckinghamshire, UK) and the equipment BioRad FX-Pro-plus (Bio-Rad Hemel 
Hempstead, UK). Densities of the bands were quantified using 1-D Analysis Software 
from Quantity One (version 4.6.8) (VilberLourmat, Marne-la-Vallée, France). 
 
14. Statistical analysis 
 
The statistical treatment of the data was done using ANOVA, followed by a t-test 
using GraphPad Prism 6 (GraphPad Software, San Diego, CA, USA). All data are 
presented as mean ± SEM. Differences with p<0.05 were considered statistically 
significant. 
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IV. Results 
 
1. Genistein is not cytotoxic for hSCs 
 
Due to the similarity of genistein with endogenous estrogens and reported cases in 
which phytoestrogens led to infertility in animals, we decided to study the effects of 
genistein on the human male reproductive system. For this work hSCs were chosen since 
these cells play a very important role in spermatogenesis as they serve as physical and 
nutritional support for germ cells. In addition, these cells possess ERs, which makes them 
potential targets of phytoestrogens in the male reproductive system. Firstly, we studied 
possible cytotoxic effects of genistein on hSCs by choosing some concentrations (in µM: 
0; 0.01; 0.1; 1; 10) which has already been mentioned above.  
To investigate whether cell death occurred in cells exposed to genistein, we chose 
to measure LDH activity. This enzyme is responsible for the conversion of pyruvate to 
lactate and is usually located in the intracellular medium. When cell lysis occurs, this 
enzyme is released into the extracellular medium, so we measured its activity in the 
medium to which the cells were exposed for 24h. In the medium, wherewith cells were 
treated with concentrations of 0.01 μM and 1 μM of genistein, there was slightly lower 
activity of this enzyme to 0.93 ± 0.06 and 0.97 ± 0.02 fold variation to control, respectively, 
as compared to the control group which is 1 ± 0.04 (Fig. 4). On the other hand, in the 
media containing 0.1 μM and 10 μM of genistein there was a slight increase in activity of 
this enzyme, to 0.97 ± 0.02 and 1.11 ± 0.05, but not significant.  
SRB assay, which allows us to detect whether there is an increase or decrease in 
cell proliferation, has shown, that cells, that were exposed to the medium containing a 
concentration of 0.01 μM of genistein slightly decreased their proliferation to 91.18 ± 
9.14% (fold variation to control) compared to the control group (100 ± 19.87%) (Fig. 4). 
Interestingly, cells exposed to concentrations of 0.1 μM, 1 μM and 10 μM of genistein 
increased their proliferation slightly, to 113.96 ± 6.94%, 117.63 ± 4.75%, 108.77 ± 
15.96%, respectively (Fig. 4). 
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In order to determine if cells were metabolically viable, the MTT assay were 
performed. This test depends on NAD(P)H, which cells can produce only if they are 
viable, for the reduction of tetrazolium dye to its insoluble form which can be detected due 
to its purple color. Interestingly, all genistein-treated groups slightly increased their 
metabolic function to 1.15 ± 0.08, 1.02 ± 0.09, 1.11 ± 0.08 and 1.23 ± 0.12 fold variation to 
control, after exposure to 0.01, 0.1, 1 and 10 μM of genistein, respectively, when 
compared to the control group which presented a value of 1 ± 0.24 (Fig. 4).  
Another important component in cellular functioning is mitochondria, which are 
responsible for the production of energy in cells. ATP production is supported by the 
electron transport chain which is located on the inner membrane of the mitochondria and 
generates electrochemical proton gradient. This gradient is measured as membrane 
potential and can be detected with the aid of JC-1 dye. In genistein-treated cells, a slight 
increase in membrane potential was observed (1.09 ± 0.09, 1.14 ± 0.07, 1.01 ± 0.08, 1.15 
± 0.09 after exposure to 0.01, 0.1, 1 and 10 μM) when compared to the control group (1 ± 
0.17), all as fold variation to control, but was not significant (Fig. 4).  
Figure 4 – Effect of different concentrations (0 µM, 0.01 µM, 0.1 µM, 1 µM, 10 µM) of genistein on 
hSCs survival rates (A), proliferation (B), metabolic activity (C) and mitochondrial viability (D). Each 
of this experiment was conducted separately and values are expressed as fold variation to control. 
Results are expressed as mean ± SEM (n=6 for each condition). Significantly different results 
(P<0.05) are indicated as (a) relative to every group. In this case, graphic D, (a) represents the 
positive control, these cells were treated with FCCP whose role is to disrupt mitochondrial 
membrane potential.  
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All of the alterations mentioned above were not significant, based on the statistical 
tests performed. 
 
2. Exposure of hSCs to genistein did not alter their lactate production 
metabolic pathway 
 
Since genistein is not toxic to hSCs, we studied if it affected the metabolism of 
these cells and, so we choose one of the main metabolic pathway for spermatogenesis, 
glycolysis, which can be summarized as production of lactate from glucose. 
Lactate is crucial since it is exported to the extracellular medium, where it is 
uptaken by germ cells and used as source of energy. Conversion of lactate is mediated by 
the enzyme LDH and therefore we measured its intracellular activity. Cells exposed to 
0.01 μM concentration slightly decreased the amount of LDH activity (0.72 ± 0.35, fold 
variation to control) when compared to the control group (1 ± 0.50) (Fig. 5). In cells 
exposed to genistein in the concentrations of 1 and 10 μM the decrease in LDH activity 
was most noticeable, 0.13 ± 0.04 and 0.09 ± 0.05, respectively (Fig. 5), however not 
significant. Nevertheless, we cannot completely ignore that, with the higher concentrations 
of genistein, LDH activity tended to decrease. Also, we measured LDH protein expression, 
which increased slightly in the groups exposed to 1 μM and 10 μM, 1.29 ± 0.31 and 1.37 ± 
0.29 as fold variation to control, respectively. Group treated with 0.01 μM (0.93 ± 0.19, fold 
variation to control) of genistein remained closer to the control group (1 ± 0.22), no 
significant variations were found.  
An analysis of ¹H-NMR allowed us to analyze the amount of metabolites present in the 
medium. We selected the most relevant for these cells taking in consideration previous 
studies from our team.  Glucose uptake, decreased from 14.78 ± 7.17 mmol/10⁶ cells in 
the control group, to 4.48 ± 0.83 mmol/10⁶ cells in cells exposed to 0.01 μM of genistein 
and to 6.40 ± 1.54 mmol/10⁶ cells in 10 µM group (Fig. 6). Interestingly, the group treated 
with 1 μM of genistein increased its uptake to 21.45 ± 10.97 mmol/10⁶ cells (Fig. 6). The 
glucose in turn is converted to pyruvate, uptake of which did not vary significantly between 
the groups, only in the group treated with 1 μM of genistein, was observed a tendency to 
increase (0.88 ± 0.37 mmol/10⁶ cells) with respect to the other groups of cells exposed to 
0, 0.01 and 10 μM (0.60 ± 0.26, 0.61 ± 0.16 and 0.50 ± 0.18 mmol/10⁶ cells, respectively) 
(Fig. 6). Pyruvate is converted to lactate which is then exported and consumed by 
developing germ cells. Lactate production slightly increased in groups treated with 1 μM 
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and 10 μM of genistein, to 15.92 ± 3.61 and 17.37 ± 4.13 mmol/10⁶ cells, respectively, 
compared to the control group that produced 15.61 ± 3.60 mmol/10⁶ cells (Fig. 6). Groups 
treated with 0.01 μM increased its lactate excretion little more than the other groups, to 
18.03 ± 3.35 nmol/106 cells (Fig. 6). However, pyruvate can also be converted to alanine, 
whose production also did not have significant variations relative to the control group (0.24 
± 0.11 mmol/10⁶ cells), only the group treated with 0.01 μM had a slight increase in the 
production of pyruvate (0.37 ± 0.09 mmol/10⁶ cells) (Fig. 6). Based on statistical tests, 
differences found are not significant. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5 – Variation on lactate dehydrogenase (LDH) intracellular activity (A) and its protein 
expression (B) in hSCs exposed to different genistein concentrations (0 µM, 0.01 µM, 1 µM, 10 µM).  
Different experiments results are presented together. Results are presented as fold variation to control 
and as mean ± SEM (n=5 for each condition).  
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3. Genistein did not alter glutamine and acetate uptake by hSCs 
 
Other components that can be found in the extracellular medium and that are 
crucial for hSCs metabolism are glutamine and acetate. These molecules participate in 
different metabolic pathways and are also used for energy production by entering the 
tricarboxylic acid (TCA) cycle via Acetyl CoA. In genistein-treated hSCs acetate uptake 
had a decrease which was more evident in groups treated with 0.01 and 10 μM (0.03 ± 
0.04 and 0.03 ± 0.02 mmol/10⁶ cells, respectively). On the other hand, the group treated 
with 1 μM (0.08 ± 0.14 mmol/10⁶ cells) was very close to the control group (0.10 ± 0.08 
mmol/10⁶ cells) (Fig. 7). In the case of glutamine, a decrease in uptake was observed in 
groups treated with 0.01 and 10 μM of genistein, to values 0.65 ± 0.56 and -0.05 ± 0.29 
mmol/10⁶ cells, respectively, while the group treated with 1 μM increased its uptake to 
2.44 ± 1.58 mmol/10⁶ cells, compared to the control group that had a value of 1.53 ± 1.04 
Figure 6 – Variation on glucose uptake (A), pyruvate uptake (B), lactate excretion (C) and alanine 
excretion (D) in hSCs exposed at different genistein concentrations (0 µM, 0.01 µM, 1 µM, 10 
µM). Consumption and excretion are presented in mmol/10⁶ cells. Results are expressed as 
mean ± SEM (n=6 for each condition).  
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mmol/10⁶ cells (Fig. 7). Nevertheless, the differences found were not statistically 
significant. 
 
4. Exposure of hSCs to genistein did not alter protein carbonylation and 
nitration but slightly increased lipid peroxidation 
 
Cellular metabolism gives rise to reactive oxygen species (ROS) that can cause 
cell damage at different levels if they are not efficiently eliminated by the cell, this is called 
oxidative stress (OS). Lipid peroxidation, carbonylation and nitration of proteins are strong 
biomarkers of OS hence they are often used to evaluate it. Products of these reactions 
can be detected and quantified thus allowing us to evaluate the severity of OS. In order to 
quantify the protein carbonylation, DNP groups are detected. They are a result of the 
derivatization mentioned above, and in the genistein-treated hSCs there was no 
significant change in their amount relative to the control group (1 ± 0.10), only a slight 
decrease (Fig. 8). Groups treated with 0.01, 1 and 10 μM had values of 0.85 ± 0.02, 0.88 
± 0.08 and 0.84 ± 0.07, fold variation to control, respectively (Fig. 8). Another effect of OS 
on proteins is their nitration, in this case it is evaluated the amount of nitrotyrosine, which, 
as happened with carbonylation, did not alter much, only slightly decreased to 0.94 ± 0.07 
and 0.90 ± 0.08 fold variation to control, in groups of hSCs treated with 1 μM and 10 μM 
respectively, compared to the control having a value of 1.04 ± 0.07 (Fig. 8). Only the 
group treated with 0.01 μM had a slight rise (1.07 ± 0.06, variation to control) but did not 
Figure 7 – Variation on acetate (A) and glutamine (B) uptake by hSCs exposed to different genistein 
concentrations (0 µM, 0.01 µM, 1 µM, 10 µM). Uptake is presented in mmol/10⁶ cells and results are 
expressed as mean ± SEM (n=6 for each condition).  
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differ that much from the control group (Fig. 8). As for lipid peroxidation, slight variations 
were detected. There was a slight increase, in cells treated with genistein, to 1.17 ± 0.21, 
1.22 ± 0.20 and 1.29 ± 0.27 fold variation to control, in groups treated with 0.01 µM, 1 µM 
e 10 µM, respectively (Fig. 8), compared to the control group whose value was 1 ± 0.13. 
However, statistical tests considered these variations as not significant. 
 
Figure 8 – Effect of genistein, at different concentrations (0 µM, 0.01 µM, 1 µM, 10 µM), on oxidative 
stress in hSCs. Here is represented data from independent experiments, which sums protein level of 
carbonylation, nitration and lipid peroxidation. Results are expressed as mean ± SEM (n=5 for each 
condition) and as fold variation to control.  
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V. Discussion 
 
Phytoestrogens are compounds produced by plants for their defense against 
pathogens (138), but their chemical similarity with animal estrogens aroused the interest 
of scientists for their possible effects in health. Many plants have these compounds, 
however, of those that are consumed by humans stands out the bean family which 
present a higher percentage of phytoestrogens (47, 139). Within this family, soy has 
become the focus of intense research due to large amounts of phytoestrogens that it 
possesses relative to other beans, it is especially rich in genistein and daidzein (74, 140). 
However, daidzein has less affinity with ERs that genistein (47, 57), which made it the 
main phytoestrogen of interest to scientific studies that aim to study hormonal-dependent 
processes.  
The similarity of genistein to animal estrogens has not immediately aroused much 
interest. This changed when it has been reported a case where phytoestrogens led to 
infertility in sheep grazing in fields that had predominantly clover (6), which are rich in 
different types of phytoestrogens, including genistein although it is not the predominant 
one here. This study, consubstantiated by many others showing both, positive and 
negative effects in animal health, Table 1 and (141, 142), led to the discussion concerning 
the consumption of some products of plant origin present in the human diet, which are 
very rich in phytoestrogens. The safety consumption of those products has been a matter 
of intense debate. Thus, several studies have been performed in an attempt to understand 
its influence on health. For instance, several studies already demonstrated some 
mechanisms of action of phytoestrogens in systems and organs, including the discovery 
that phytoestrogens are able to inhibit tyrosine kinase and topoisomerase II (81-85), which 
are important proteins in cell replication and, therefore, potential targets in cancer 
treatment. Meantime other beneficial functions have been attributed to phytoestrogens 
due to their estrogenic action, although a weak one. It has been shown that it is capable of 
producing beneficial effects in estrogen-regulated systems, such as bone remodeling, 
thereby preventing osteoporosis, alleviating menopausal symptoms, reducing the risk of 
cardiovascular and cancer diseases, delaying skin aging, boosting the immune system, 
and even improving memory. However, its action on the reproductive system remains 
unclear even after the reported cases of infertility in sheep discussed earlier. Therefore, it 
is crucial to unravel the effects of genistein in the reproduction, particularly in male 
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reproduction taking in consideration the current research that highlights a growing 
influence of estrogens for the establishment of the male reproductive potential.  
The overwhelming majority of studies were performed on rats/mice, in which they 
were subjected to different doses and types of phytoestrogens, at different stages of 
development. However, after summarizing these studies it is difficult to reach to a 
conclusion concerning the safety of phytoestrogens, and genistein, in particular, and their 
influence on human and animal fertility. The results attained in much of those studies are 
contradictory; one part of the studies claims that there are not any significant alterations 
on the reproductive system of the individuals studied while others concluded that there are 
some disturbances in the reproductive potential of the individuals studied, Table 1. 
Nevertheless, we must highlight that even evolutionarily close organisms have differences 
and this can lead to different reactions to the same compound. This was well shown in 
knockout animals for ERs and aromatase. Animals and humans sharing the same 
deficiency of either ER or aromatase enzyme had different phenotypes, although with 
some similarities, as mentioned earlier. In turn, human studies are scarce and mainly 
based on surveys and analysis of data obtained from infertility clinics, which may not be 
very reliable since other external and even internal factors may be the cause of 
abnormalities in the reproductive system. 
To study the influence of genistein on male fertility human Sertoli cells as model 
(143) were chosen. These cells serve as physical and nutritional support for 
spermatogenesis, to germ cells, providing them nutrients and metabolic intermediates 
besides forming blood-testis barrier that protects them and creates an environment 
favorable to their development (144-147). Another important factor in the choice of these 
cells is the fact that they possess ERs and our group has previously described that their 
metabolism is influenced by estrogens (148-150), which makes them potential targets of 
phytoestrogen.  
Our first approach consisted in studying if genistein was cytotoxic to hSCs. Our 
results showed that this phytoestrogen is not toxic to the hSCs as measured by the 
activity of the LDH in the extracellular medium. The normal location of this enzyme is in 
the intracellular environment, so if the amount of it increases in the extracellular medium 
this would be a sign of cell death. However, our results show that in vitro exposure of 
hSCs to the selected concentrations of genistein does not increase cell death. Differences 
were also not found in the proliferation of genistein-exposed hSCs nor in the general 
metabolic activity as measured by the SRB and MTT test, respectively. This is in 
accordance with several studies that suggest the safety of genistein in vitro or even report 
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a cytoprotective effect. This has been associated with the antioxidant properties of this 
phytoestrogen (87, 88, 117, 118).  
Another important organelle for cellular metabolism is the mitochondria, since they 
produce most of the cellular energy. Thus, although no differences were detected 
concerning the overall metabolic activity in genistein-exposed cells, we measured the 
mitochondrial membrane potential to access the number of viable mitochondria. 
Interestingly, our results suggest that the doses used in this study are not able to 
modulate mitochondrial membrane potential. This may be due to several factors, including 
the specificity of these cells. The SCs mainly produce lactate and acetate from glucose 
and only rely on the mitochondrial activity to support their own energetic needs (151) thus, 
since there is no alteration on cells proliferation nor in cell death, it would be expectable 
that mitochondria would remain functional.  
One of the main functions of hSCs is the nutritional support of spermatogenesis. 
This is mainly done by glycolysis and further conversion of pyruvate to lactate and other 
metabolites needed to the development of germ cells. Although no differences were 
detected in metabolic activity and mitochondrial membrane potential, we studied some 
mechanisms associated with glycolysis and lactate production.  In order to evaluate the 
amount of metabolites of this pathway we used ¹H-NMR analysis of the extracellular 
media. No significant differences were detected in the analyzed metabolites. 
Nevertheless, although glucose uptake did not show any significant variation, we detected 
a tendency to decrease after exposure to genistein except at the concentration of 1μM in 
which the uptake was slightly higher than in the group without genistein. The glucose 
taken by the cells is then converted to pyruvate, but pyruvate can also be taken from 
extracellular sources, including the media. Our results showed that genistein, in the doses 
tested, did not alter the uptake of pyruvate from the extracellular media though the cells 
treated with 1μM presented a slight tendency to increase in its uptake. Pyruvate can either 
be converted to lactate or into alanine or proceed to the mitochondria where it will enter 
the TCA cycle for further energy production. For germ cells, lactate production is crucial 
since they use it as an energy source. In fact, developing germ cells cannot metabolize 
glucose on their own and rely on the lactate produced by SCs that is exported to the 
lumen of the seminiferous tubules where these cells are located. Lactate excretion 
remained equal between groups as well as alanine excretion though a slight tendency in 
alanine excretion increase was observed in the group treated with 0.01μM. This is 
concomitant with the lack of effect in glucose and pyruvate uptake. We further studied if 
genistein could interfere with intracellular LDH activity or expression. LDH can convert 
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pyruvate to lactate in a bidirectional way. Our results show that genistein, in the tested 
concentrations, did not alter the activity nor the expression of this enzyme although a 
tendency to decrease the enzyme activity was observed as the genistein concentration 
increased. Curiously the inverse was observed with the expression of this protein. 
Nevertheless, these results are non-significant which suggests that further experiments 
may be needed to consolidate this tendency as irrelevant or a crucial point for the action 
of genistein in the male reproductive tract.  Taken together, our results suggest that 
lactate production and glycolysis, both essential processes for spermatogenesis, were not 
influenced by the presence of genistein. Other important metabolites for cellular 
metabolism are glutamine and acetate since they enter lipid and protein metabolism and 
can also proceed to TCA cycle through Acetyl-CoA, which results in an increase in energy 
production. Our results suggest that the exposure to genistein in the concentrations tested 
did not change the uptake of these compounds. Again, it was detected a trend to a 
decreased uptake in genistein-treated groups except for the cells treated with 1μM, where 
glutamine slightly increased its uptake. This suggests that further studies may be needed 
to completely unveil the effect of genistein in these cells as an increase in the number of 
primary cells attained from more biopsies may increase the statistical power of the results 
and consolidate the findings.   
Cellular metabolism also generates reactive oxygen species that, if not effectively 
eliminated by the cell, will cause irreversible damages in the same and can even lead to 
its death. It has already been reported that phytoestrogens have antioxidant properties 
(87, 88, 117, 118). Thus, we evaluated the effect of genistein in the oxidative profile of 
hSCs. For this we evaluated protein carbonylation and nitration, and also lipid 
peroxidation. Our results showed that genistein in the tested concentrations did not 
changed the oxidative profile of hSCs. This is concomitant with all the previous results 
showing that genistein had no effect on the metabolic activity, proliferation, mitochondrial 
activity nor in the glycolytic activity of hSCs.  
Overall, our data clearly shows that the in vitro exposure of hSCs to genistein in 
the selected concentrations is not cytotoxic and does not changes the proliferation or 
metabolic activity of these cells, including their major function in the nutrition support of 
spermatogenesis. Though all the small changes were non-significant, it is important to 
note that further studies will be necessary to characterize the mechanisms of action of 
genistein in hSCs and how it can change the metabolic functioning of these cells. 
Therefore, at this point, our results point towards the conclusion that genistein can be 
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considered safe but taken in consideration the fact that this is the first work focused on the 
effects of genistein in hSCs, cautions should be taken.  
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VI. Conclusions and Future Perspectives 
 
 
 Interest in phytoestrogens has grown exponentially in the last decades due 
to their beneficial properties on human health. Nonetheless, their similarity to animal 
estrogens, and the discovery of cases where exposure to phytoestrogens was associated 
with disturbed fertility in animals, has given rise to concerns about their safety and 
potential undesirable effects on reproductive system, which is highly regulated by 
estrogens even in men.  
 Information from the current literature is contradictory and therefore it is 
difficult to reach to a conclusion. This difference between studies is due to several factors 
and studies on animals cannot be directly extrapolated to humans due to the biological 
differences between the organisms. For example, in animals such as boars and roosters 
isoflavones appear to have beneficial effects on fertility and sperm parameters (141, 142) 
while in sheep it was associated with infertility, as mentioned above. As previously 
mentioned, animal studies can only serve as a basis to study the molecular mechanisms 
and mechanisms of action of phytoestrogens in mammals. Since human studies are 
scarce and mostly based on surveys and clinical data analysis, we studied (in vitro) the 
effects of genistein, one of the most consumed phytoestrogen by humans, on human 
Sertoli cells, which are responsible for the physical and nutritional support of 
spermatogenesis.  
 Taken together, our results show that genistein does not induce any 
significant effects on hSCs viability, metabolism and oxidative stress, however this does 
not clearly suggests that phytoestrogens, and genistein itself, are safe for the reproductive 
potential of the individuals. Further studies will be needed, particularly to consolidate the 
findings of the differences that were not considered significant by the statistical analysis. 
Those tendencies, that could influence the overall conclusions, need and deserve further 
studies . 
Also, surveillance of SIF-fed children is necessary since it is at this point in life 
(neonatal) that the testes are structurally organized, and spermatogonia and Sertoli cell 
numbers are established, which will play a significant role on spermatogenesis when it will 
begin at puberty.  
In conclusion, it is therefore necessary a greater investment on study the action of 
genistein, and other phytoestrogens, on human health, particularly on male fertility and the 
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possible effects on the quality of reproduction, because they are indeed compounds with 
great therapeutic potential and with possible beneficial effects on the body.  
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